XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2022 $ 52 $ 771,699 $ (884) $ (510,632) $ 260,235
Balance at beginning (in shares) at Dec. 31, 2022 51,672,579        
Increase (decrease) in Stockholders' Equity          
Unrealized (loss) gain on marketable securities     555   555
Sale of common shares, net of issuance costs   827     827
Sale of common shares, net of issuance costs (in shares) 68,696        
Exercise of stock options   243     243
Exercise of stock options (in shares) 28,706        
Issuance of common shares upon RSU vesting (in shares) 219,378        
Equity-based compensation expense   6,170     6,170
Other   2     2
Net Income (Loss)       (39,379) (39,379)
Balance at end at Mar. 31, 2023 $ 52 778,941 (329) (550,011) 228,653
Balance at end (in shares) at Mar. 31, 2023 51,989,359        
Balance at beginning at Dec. 31, 2022 $ 52 771,699 (884) (510,632) 260,235
Balance at beginning (in shares) at Dec. 31, 2022 51,672,579        
Increase (decrease) in Stockholders' Equity          
Unrealized (loss) gain on marketable securities         861
Net Income (Loss)         (119,663)
Balance at end at Sep. 30, 2023 $ 56 797,927 (23) (630,295) 167,665
Balance at end (in shares) at Sep. 30, 2023 56,260,574        
Balance at beginning at Mar. 31, 2023 $ 52 778,941 (329) (550,011) 228,653
Balance at beginning (in shares) at Mar. 31, 2023 51,989,359        
Increase (decrease) in Stockholders' Equity          
Unrealized (loss) gain on marketable securities     266   266
Sale of common shares, net of issuance costs $ 1 4,395     4,396
Sale of common shares, net of issuance costs (in shares) 550,594        
Exercise of stock options   292     292
Exercise of stock options (in shares) 53,333        
Issuance of common shares upon RSU vesting (in shares) 273,035        
Exercise of pre-funded and common warrants $ 2 (2)      
Exercise of pre-funded and common warrants (in shares) 2,293,466        
Equity-based compensation expense   6,818     6,818
Other   1     1
Net Income (Loss)       (37,925) (37,925)
Balance at end at Jun. 30, 2023 $ 55 790,445 (63) (587,936) 202,501
Balance at end (in shares) at Jun. 30, 2023 55,159,787        
Increase (decrease) in Stockholders' Equity          
Unrealized (loss) gain on marketable securities     40   40
Exercise of stock options   280     280
Exercise of stock options (in shares) 49,604        
Issuance of common shares upon RSU vesting (in shares) 24,290        
Exercise of pre-funded and common warrants $ 1 (1)      
Exercise of pre-funded and common warrants (in shares) 1,026,893        
Equity-based compensation expense   7,203     7,203
Net Income (Loss)       (42,359) (42,359)
Balance at end at Sep. 30, 2023 $ 56 797,927 (23) (630,295) 167,665
Balance at end (in shares) at Sep. 30, 2023 56,260,574        
Balance at beginning at Dec. 31, 2023 $ 76 901,471 92 (676,421) 225,218
Balance at beginning (in shares) at Dec. 31, 2023 75,979,495        
Increase (decrease) in Stockholders' Equity          
Unrealized (loss) gain on marketable securities     (142)   (142)
Exercise of stock options   280     280
Exercise of stock options (in shares) 47,293        
Issuance of common shares upon RSU vesting (in shares) 360,373        
Exercise of pre-funded and common warrants $ 4 6,102     6,106
Exercise of pre-funded and common warrants (in shares) 3,357,493        
Equity-based compensation expense   8,164     8,164
Net Income (Loss)       (56,853) (56,853)
Balance at end at Mar. 31, 2024 $ 80 916,017 (50) (733,274) 182,773
Balance at end (in shares) at Mar. 31, 2024 79,744,654        
Balance at beginning at Dec. 31, 2023 $ 76 901,471 92 (676,421) 225,218
Balance at beginning (in shares) at Dec. 31, 2023 75,979,495        
Increase (decrease) in Stockholders' Equity          
Unrealized (loss) gain on marketable securities         36
Net Income (Loss)         (179,840)
Balance at end at Sep. 30, 2024 $ 80 935,249 128 (856,261) 79,196
Balance at end (in shares) at Sep. 30, 2024 80,081,535        
Balance at beginning at Mar. 31, 2024 $ 80 916,017 (50) (733,274) 182,773
Balance at beginning (in shares) at Mar. 31, 2024 79,744,654        
Increase (decrease) in Stockholders' Equity          
Unrealized (loss) gain on marketable securities     (4)   (4)
Exercise of stock options   47     47
Exercise of stock options (in shares) 6,617        
Issuance of common shares upon RSU vesting (in shares) 240,797        
Equity-based compensation expense   9,312     9,312
Net Income (Loss)       (58,508) (58,508)
Balance at end at Jun. 30, 2024 $ 80 925,376 (54) (791,782) 133,620
Balance at end (in shares) at Jun. 30, 2024 79,992,068        
Increase (decrease) in Stockholders' Equity          
Unrealized (loss) gain on marketable securities     182   182
Exercise of stock options   223     223
Exercise of stock options (in shares) 41,078        
Issuance of common shares upon RSU vesting (in shares) 48,389        
Equity-based compensation expense   9,650     9,650
Net Income (Loss)       (64,479) (64,479)
Balance at end at Sep. 30, 2024 $ 80 $ 935,249 $ 128 $ (856,261) $ 79,196
Balance at end (in shares) at Sep. 30, 2024 80,081,535